What payment terms are accepted?

We accept T/T, Western Union, and small-amount payments.

What certifications does the product have?

The product meets Enterprise Standards certification.

What is the physical appearance of the product?

Dihydromyricetin appears as a white powder.

High Quality Natural Herbal Extract Dihydromyricetin CAS 27200-12-0

Name: High Quality Natural Herbal Extract Dihydromyricetin CAS 27200-12-0
Brand: Wuhan Hengheda Pharm Co., Ltd.
SKU: 1917064902

Hubei, ChinaWuhan Hengheda Pharm Co., Ltd.

US$1.00-2.00

100 Pieces

Product profile

Customization

Available

Powder

Yes

Customized

Non-Customized

Model NO.

CAS 27200-12-0

Certification

Enterprise Standards

Suitable for

Adult

State

Powder

Purity

>98%

Color

White

Grade

Pharmaceutical Grade

Transport Package

Alumininum Foli Bags

Specification

10g, 50g, 200g, 1kg, 5kg

Trademark

hhdpharm

Origin

China

Key features

High Purity Content: Dihydromyricetin purity exceeds 98%, verified by HPLC and UV test methods.

Liver Protection: Helps prevent alcoholic liver disease, fatty liver, and inhibits liver cell progression.

Antioxidant Effects: Acts as a free radical scavenger with anti-inflammatory and anti-tumor properties.

Immunity Enhancement: Improves SOD activity and enhances body immunity when used as a health supplement.

Low MOQ Availability: Minimum Order Quantity is just 1 KG, suitable for small-scale testing or purchase.

Custom Synthesis Support: Offers full customization and sample-based synthesis services for specific needs.

Multiple Application Fields: Suitable for feed industry, health products, and pharmaceutical capsules or pills.

Established Manufacturer: 15 years of export experience with 2 production lines and dedicated QA/QC team.

Company profile

Importers and ExportersFull CustomizationODM ServicesQuality Assurance

Wuhan Hengheda Pharm Co., Ltd.

Hubei, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Full Customization CertifiedExport Year: 15 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤10.87h

AI-Powered supplier vetting

SummaryWuhan Hengheda Pharm Co., Ltd. is a China-based limited manufacturing company established in 2013, with 27 employees and operations in Hubei. It specializes in pharmaceutical intermediates, APIs, fine chemicals, natural extracts, food additives, health-related products, custom synthesis, and related OEM services. The supplier reports a 1,000-square-meter R&D and pilot-scale platform, three production lines, and a cooperative production base with 50L–2,000L reaction vessels and tonnage-level R&D and production capacity. It exports 41%–50% of total sales and began exporting in 2012. An SGS audit is recorded, but the audit result is coded as 0 and the stated validity period ended on 2025-07-21; the meaning of the result code is not provided. Most service, quality-system, customer-case, and certification details remain unknown, so several fields cannot be conclusively assessed.

Supplier typeThe supplier is identified as Wuhan Hengheda Pharm Co., Ltd., a Chinese limited company and factory located in Hubei. Its stated business focuses on custom synthesis, manufacture, and import/export of fine chemicals, APIs, and pharmaceutical intermediates.

R&D capabilityThe supplier reports a 1,000-square-meter R&D and pilot-scale platform with modern experimental equipment and the ability to conduct small-scale research and pilot production of compounds. The records also state two years of R&D engineer experience, but product-launch, ODM, SDK, and other innovation indicators are unknown.

Production capacityThe supplier reports three production lines and a cooperative production base exceeding 30 mu, equipped with stainless-steel and glass-lined vessels ranging from 50L to 2,000L. It states that the base supports tonnage-level R&D and production, providing explicit evidence of substantial production infrastructure.

Customization capabilityCustom synthesis is listed among the supplier's primary offerings, and the company describes R&D and pilot-scale capabilities for producing various compounds. These statements directly support customization for chemical and pharmaceutical-related products, although specific project examples and service procedures are not provided.